ALKS vs HOLX · P/E 14, rev $1.56B vs P/E 32, rev $4.10B
Alkermes Plc (ALKS) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the ALKS and HOLX stock pages for the full models.
Not investment advice.